Mai Capital Management Vista Gen Therapeutics, Inc. Transaction History

Mai Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.12 - $0.3 $3,936 - $9,842	-32,808 Reduced 5.31%	584,925 $70,000
Q4 2022 Feb 09, 2023	SELL	$0.09 - $4.8 $111,232 - $5.93 Million	-1,235,917 Reduced 66.67%	617,733 $61,000
Q3 2022 Nov 15, 2022	SELL	$0.14 - $4.8 $113,084 - $3.88 Million	-807,748 Reduced 30.35%	1,853,650 $282,000
Q2 2022 Jul 19, 2022	BUY	$0.88 - $1.73 $2.34 Million - $4.6 Million	2,661,398 New	2,661,398 $2.34 Million

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.